The Retina World Congress showcases global innovations in surgical and medical retina, highlighting emerging treatments and ...

In a breakthrough poised to reshape how the United States tackles tick-borne diseases, Nigerian scientist Kosisochukwu ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

This valuable study investigates how stochastic and deterministic factors are integrated during cellular decision-making, particularly in situations where cells differentiate into distinct fates ...

Despite widespread support and an unassailable Democratic majority in both Colorado’s state House and Senate, House Bill 1312 ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

US biotech Lexeo Therapeutics has secured $80 million from a private placement, giving the company enough capital to push ...

Rett syndrome market dynamics are expected to undergo significant shifts as more targeted therapies, including gene therapies and pharmacological interventions, enter clinical development and ...

Rett syndrome is a rare genetic neurological condition that typically emerges in infancy and primarily affects girls, though occasional cases have been observed in boys. The disorder causes profound ...

Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...

New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus ...